Groww Logo
Home>US Stocks>Bristol-Myers Squibb Co

Bristol-Myers Squibb Co

Healthcare
$76.19
+ $0.23 (0.30%) 1D
1D
1W
1M
1Y
3Y
5Y

Performance

Today’s Low
$
    Today’s High
    $
    52W Low
    $
      52W High
      $
      Open PricePrev. CloseVolumeAvg. Volume
      $76.50$75.9617,329,67815,533,558

      Fundamentals

      Market Cap$162.21B
      P/B Ratio5.1
      P/E Ratio25.9
      Enterprise Value$194.81B
      Div. Yield2.84%
      Book Value14.83
      EPS(TTM)2.84
      ROE17.70%
      Understand Fundamentals

      About the Company

      Headquartered in 430 East 29th Street, New York City, Bristol-Myers Squibb is an American Pharmaceutical company. It is also known as BMS, and its origin dates back to 1885 when Dr Edward Robinson Squibb, opened his first laboratory in Brooklyn, New
      Headquartered in 430 East 29th Street, New York City, Bristol-Myers Squibb is an American Pharmaceutical company. It is also known as BMS, and its origin dates back to 1885 when Dr Edward Robinson Squibb, opened his first laboratory in Brooklyn, New York. Soon after that in 1887, William Bristol and John Myers purchased the failing Clinton Pharmaceutical Company, and by 1899 it officially became Bristol-Myers Company. After the death of Dr Squibb, the company was left to his two sons in 1900. Dr Squibb aimed to provide safe and reliable medication to everyone and Bristol and Myers aimed to refrain from selling “quack remedies”. With similar aims, the two companies collaborated for the first time in 1956 for early Cancer research. After more than three decades in 1989, the two companies officially merged to form the Bristol-Myers Squibb Company. Together, it became the world’s second-largest pharmaceutical company. Its first medicine introduced was PARAPLATIN. Since then it has developed an array of medicines for critical diseases, including AZACTAM, ELIQUIS, IDHIFA, BARACLUDE, OPDIVO, INREBIC, VIDAZA, etc. The company also offers its legacy products such as ATRIPLA, LYSODREN, PLAVIX, VIDEX, COUMADIN, etc. BMS focuses on four broad areas that are Immunoscience, Oncology, Fibrosis and Cardiovascular. It also focuses on ten drug platforms, namely Epigenetics, RNA Oligonucleotides, Antibody-Drug Conjugates, Small Molecules, Cell Therapy, Gene Therapy, Protein Homeostasis, Drug Delivery Technology, Millamolecules and Biologics. The company started to expand by acquiring and merging with other established businesses. Between 2009 and 2020 it acquired Medarex in 2009, ZymoGenetics in 2010, iPierian in 2014, Flexus Biosciences in 2015, Padlock Therapeutics in 2016, IFM Therapeutics in 2017 and Clegen in 2019. In 1998 it was awarded the National Medal of Technology by Bill Clinton for its innovative pharmaceutical research and efforts towards enhancing human life. It is the most prestigious award in the field of technological innovation in the US. It was back in 1929 when Bristol and Myers went public under the symbol BMY. In its trading history under the New York Stock Exchange.
      ...Read more
      OrganisationBristol-Myers Squibb Co
      IndustryDrug Manufacturers—General
      HeadQuartersNew York, NY

      Company Financials

      *All values are in Million $
      No Graph Data To Display
      Quarterly
      Yearly
      See Details

      FAQs on Bristol-Myers Squibb Co

      Can I Buy Bristol-Myers Squibb Co Shares in India?

      Yes, Bristol-Myers Squibb Co shares can be bought in India by opening an international trading account with Groww.

      How to Buy Bristol-Myers Squibb Co Shares in India?

      One can easily invest in Bristol-Myers Squibb Co shares from India by: Direct Investment - Opening an international trading account with Groww which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Bristol-Myers Squibb Co shares. Indirect Investment - Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Bristol-Myers Squibb Co.

      What is the Share Price of Bristol-Myers Squibb Co?

      The share price of Bristol-Myers Squibb Co is in Dollars and if you are investing from India, you can always check the INR valuation before investing. The current Bristol-Myers Squibb Co share price is $76.19 as of 20 May ‘22

      What is the Market Cap of Bristol-Myers Squibb Co?

      The Bristol-Myers Squibb Co market cap is $162.21B as of 20 May ‘22

      What is the PE and PB ratio of Bristol-Myers Squibb Co?

      The PE and PB ratio of Bristol-Myers Squibb Co is 25.9 and 5.1 as of 20 May ‘22
      ⓒ 2016-2022 Groww. All rights reserved, Built with in India
      MOST POPULAR ON GROWWVERSION - 2.3.8
      STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
      MUTUAL FUNDS COMPANIES:  ICICI PRUDENTIAL |  HDFC |  NIPPON INDIA |  ADITYA BIRLA SUN LIFE |  SBI |  UTI |  FRANKLIN TEMPLETON |  KOTAK MAHINDRA |  IDFC |  DSP |  AXIS |  TATA |  L&T |  SUNDARAM |  PGIM |  INVESCO |  LIC |  JM FINANCIAL |  BARODA PIONEER |  CANARA ROBECO |  HSBC |  IDBI |  INDIABULLS |  MOTILAL OSWAL |  BNP PARIBAS |  MIRAE ASSET |  PRINCIPAL |  BOI AXA |  UNION KBC |  TAURUS |  EDELWEISS |  NAVI |  MAHINDRA |  QUANTUM |  PPFAS |  IIFL |  Quant |  SHRIRAM |  SAHARA |  ITI

      ABOUT GROWW